|

Important UPDATE : MindMed’s 2020 Year-End Financial Results [ Good News for MMED / MMEDF! ]

Hey Psychedelic Investors! For those of you following MindMed, today’s episode is based on MindMed’s press release where MMED announced their 2020 year-end Financial results.

What was covered in MindMed’s press release?
1. MMED ‘ s total assets
2. MindMed’s Net Cash Operating Activities
3.MMEDF ‘s Net loss
4. The company’s Cash on Hand
5. The date and hour for MindMed ‘s earnings call

MMED / MMEDF / MMQ ‘ stock has been experiencing a little fall lately… As long as the price doesn’t fall below $2 USD, we should still be good-ish in terms of the NASDAQ stock price requirements.. Hopefully it won’t fall below that threshold!

I hope you guys found some value in this and I’ll keep you posted for more changes!

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://mindmed.co/news/press-release/mindmed-announces-2020-year-end-financial-results-current-cash-balance-of-161-million-usd-203-million-cad-to-support-drug-development-pipeline-and-creation-of-psychedelic-medicine-tech-platform/

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

#MindMed​​ ​#MindmedStock​​ #MMEDNews

Similar Posts

  • The Awakening of Consciousness Conference with Paul Karasik

    In this episode, Matthew and Paul discuss The Psychedelic Institute’s aspirations with the launch of the Awakening of Consciousness Conference, the differences between legalization and decriminalization, and the importance of being brave, and thinking outside the box in understanding what it takes to make the most of one’s own experience of sacred plant medicines.

  • Exploring Integrative Therapy and Altered States of Consciousness with Lana Rados, Intronaut

    In today’s episode, Lana describes her journey from being a clinically-focused empiricist to eventually opening up to the possibilities of mystical states of consciousness, discusses how plant medicine can be effective for healing all levels of trauma, and updates us on her view of the clinical and spiritual perspectives of psychedelic-assisted psychotherapy.

  • Interview with Joseph Mays, IRI Program Director at Chacruna

    In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us to understand the Indigenous philosophy of interrelatedness between one another and our ecosystems, the importance of considering sacred reciprocity to Indigenous peoples and their land, and how Chacruna’s Indigenous Reciprocity Initiative is making it simple for companies to give back to the societies who have cultivated psychedelic medicine.

  • BIG Updates On MindMed, Compass, NUMI, TRYP, TRUFF, LOBE & More Plus Clinical Trial Progress

    Hey psychedelic investors, this week we have Big Updates on MindMed, Compass, NUMI TRYP, TRUFF, ATAI, SHRM and LOBE Sciences and some amazing Ayahuasca study results which are detrimental to DMT research and this molecule potential effects on depression and anxiety.

    Timestamps:
    0:00 – Intro
    0:52- Effects of DMT, taken using the ayahuasca drink, on depression and anxiety
    5:26 – MindMed ( MMED / MNMD / MMQ ) stared trading on NASDAQ
    6:01 – MindMed finishes phase2a trials for Project LUCY
    8:15 – Atai Life Sciences To IPO soon on the Nasdaq and plans to raise $100 million
    9:17 – Compass Pathways ( CMPS) to raise $144 million dollars
    10:35 – Numinus Wellness ( NUMI ) to begin phase 1 trial for naturally extracted psilocybin in their lab
    12:15 TRYP Therapeutics (TRYP) to begin 2 phase 2a trials in 2021
    13:50 – Champignon Brands (SHRM) to restart trading in Canada
    14:31 – Lobe Sciences (LOBE) & Core one Labs ( CLABF) to create a Joint Venture
    15:34 – Red Light Holland (TRUFF) has increased its points of sale by 144% and TRUFF and Halo Collective create Red Light Oregn, INC

    Link to Numinus (NUMI) press release: https://www.newswire.ca/news-releases/numinus-announces-phase-1-clinical-trial-of-natural-psilocybin-mushroom-extraction-prepared-at-company-lab-879795202.html?fbclid=IwAR1SmpbsTmXLs-mEy3vsUtAGKKk_xpf3FxJB3n2C-55zGJjiF0naXRetoUs

    Link to Compass Pathways (CMPS) : https://www.globenewswire.com/news-release/2021/04/27/2218191/0/en/COMPASS-Pathways-launches-proposed-public-offering.html https://ir.compasspathways.com/static-files/fe6cc477-a2ee-4b4a-bd46-8f8df0b62f30

    Link To Atai life Sciences: https://www.atai.life/

    Link To MindMed (MMED / MNMD / MMQ) https://mindmed.co/
    Link to MindMed clinical trial: https://clinicaltrials.gov/ct2/show/NCT03153579?term=lsd+anxiety&draw=2&rank=1

    Link to Red LIght Holland (TRUFF) : https://www.newsfilecorp.com/release/81879/Red-Light-Holland-and-Halo-Collective-Create-Red-Light-Oregon-Inc.-Forwarding-Intentions-to-Enter-Oregon-Medicinal-Psychedelic-Market
    https://www.cnbc.com/2021/04/21/atai-ipo-peter-thiel-backed-psychedelics-firm-to-raise-100-million.html

    Link to Champignon Brands (SHRM) : https://www.prnewswire.com/news-releases/champignon-brands-announces-revocation-of-cease-trade-orders-301275526.html

    Link to DMT study: https://www.sciencedirect.com/science/article/pii/S2666915321000251?fbclid=IwAR1-0HC9fxkL2Z47TEubMGsrqKInj61xLvBK4OW_C3FEQgv5VomoCSoNeQo

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #PsychedelicStocks #numiStock